Skandinaviska Enskilda Banken (SEB)’s Health Catalyst HCAT Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-35,036	Closed	-$508K	–	958
2022 Q2	$508K	Buy	35,036 +16,686	+91%	+$284K	﹤0.01%	806
2022 Q1	$479K	Sell	18,350 -9,109	-33%	-$258K	﹤0.01%	840
2021 Q4	$1.11M	Hold	27,459	–	–	0.01%	755
2021 Q3	$1.37M	Sell	27,459 -9,922	-27%	-$541K	0.01%	733
2021 Q2	$2.08M	Buy	37,381 +1,026	+3%	+$54.7K	0.01%	653
2021 Q1	$1.7M	Buy	36,355 +5,276	+17%	+$256K	0.01%	703
2020 Q4	$1.35M	Buy	+31,079	New	+$1.15M	0.01%	756

Other funds holding HCAT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s HCAT Position: Q3 2022 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Health Catalyst (HCAT) in Q3 2022, closing a stake of 35,036 shares — an estimated $508K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in HCAT in Q4 2020 and held it in 7 quarters. The position peaked at $2.08M in Q2 2021. 171 funds tracked by Wall St. Rank hold HCAT as of Q3 2022.

Skandinaviska Enskilda Banken (SEB) reported no remaining Health Catalyst position as of Q3 2022 after selling out during the quarter.
Skandinaviska Enskilda Banken (SEB) sold 35,036 Health Catalyst shares in Q3 2022, an estimated $508K.
Skandinaviska Enskilda Banken (SEB) first reported a position in Health Catalyst in Q4 2020 and held it in 7 quarters.
Skandinaviska Enskilda Banken (SEB)'s Health Catalyst position peaked at $2.08M in Q2 2021.
171 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2022.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2022, filed 14 Nov 2022.